Stem cells allow us to study fundamental processes in tissue growth, development, aging and disease. The next waves of medicine will build on personalised therapies for drug treatments that require an understanding of drug-genetic-tissue interactions. Stem cell programs that can direct the differentiation of cells lead to the assembly of mini-organs in a dish that are already in use for disease screening in Australia, and around the world.
The BPA Stem Cell Collaborative Data Initiative aims to deliver multi-omics data to support national research efforts in Stem Cell biology. The end goal of this nationally collaborative program is to provide a public resource (data and methodology) that will enable a broad scope of future research endeavors. All datasets are generated through the consortium that comprises the expert input of leading stem cell researchers, omics platform specialists and a designated scientific steering committee. The advantage of this type of initiative is the generation of new linkages and research partnerships.